Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata

NCT03137381 is registered in ClinicalTrials.gov with Concert Pharmaceuticals as lead sponsor.

NCT NCT03137381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03137381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
Lead sponsor
Concert Pharmaceuticals
Phase
Phase 2
Overall status
Completed
Start date
August 9, 2017
Completion date
July 8, 2019
Enrollment
149 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

alopecia areata